cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Charles River Laboratories International
8 own
7 watching
Current Price
$209.47
$-2.97
(-1.4%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
12,325.82M
52-Week High
52-Week High
275.00000
52-Week Low
52-Week Low
161.64999
Average Volume
Average Volume
0.41M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
48.7805
iconMarket Capitalization12,325.82M
icon52-Week High275.00000
icon52-Week Low161.64999
iconAverage Volume0.41M
iconDividend Yield--
iconP/E Ratio48.7805
What does the Charles River Laboratories International do?
Charles River Laboratories International, Inc., an early-stage contract research company, provides drug discovery and development services worldwide. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Support (Manufacturing). The RMS segment produces and sells research model strains primarily genetically and microbiologically defined purpose-bred rats and mice for use by researchers. This segment also provides a range of services to assist its clients in supporting the use of research models in research and screening preclinical drug candidates comprising genetically engineered models and services, insourcing solutions, and research animal diagnostic services. The DSA segment offers early and in vivo discovery services for identification of a druggable target through delivery of preclinical drug and therapeutic candidates ready for safety assessment; and safety assessment services, which comprise bioanalysis, pharmacokinetics, drug metabolism, toxicology, and pathology services. The Manufacturing segment provides in vitro methods for conventional and rapid quality control testing of sterile and non-sterile biopharmaceuticals, and consumer products. This segment also offers specialized testing of biologics and devices that are outsourced by pharmaceutical and biotechnology companies; and avian vaccine services that provide specific-pathogen-free fertile chicken eggs and chickens used in the manufacture of live viruses. The company serves pharmaceutical and biotechnology companies, contract research organizations, agricultural and chemical companies, life science and veterinary medicine companies, contract manufacturing organizations, medical device companies, diagnostic and other commercial entities, hospitals, academic institutions, and government agencies. Charles River Laboratories International, Inc. was founded in 1947 and is headquartered in Wilmington, Massachusetts.
Read More
How much money does Charles River Laboratories International make?
News & Events about Charles River Laboratories International.
Globe Newswire
11 months ago
NEW ORLEANS, July 04, 2023 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until July 18, 2023 to file lead plaintiff applications in a securities class action lawsuit against Charles River Laboratories International, Inc. (NYSE: CRL), if ...
Globe Newswire
11 months ago
Did you lose money on investments in Charles River? If so, please visit Charles River Laboratories International, Inc. Shareholder Class Action Lawsuit or contactPeter Allocco at (212) 951-2030orpallocco@bernlieb.com to discuss your rights. NEW YORK, July 05, 2023 (GLOBE NEWSWIRE) -- Bernstein ...
Globe Newswire
11 months ago
LOS ANGELES, July 05, 2023 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP (GPM) reminds investors of the upcomingJuly 18, 2023 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Charles River Laboratories International, Inc...
Business Wire
11 months ago
The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been against Charles River Laboratories International, Inc. (Charles River) (NYSE: CRL). The action charges Charles River with violations of the federal securities...
Globe Newswire
11 months ago
NEW YORK, July 03, 2023 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Charles River Laboratories International, Inc. ("Charles River" or the "Company") (NYSE: CRL) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Charles River...
Frequently Asked Questions
Frequently Asked Questions
What is Charles River Laboratories International share price today?
plus_minus_icon
Can Indians buy Charles River Laboratories International shares?
plus_minus_icon
How can I buy Charles River Laboratories International shares from India?
plus_minus_icon
Can Fractional shares of Charles River Laboratories International be purchased?
plus_minus_icon
What are the documents required to start investing in Charles River Laboratories International stocks?
plus_minus_icon
What is today’s traded volume of Charles River Laboratories International?
plus_minus_icon
What is today’s market capitalisation of Charles River Laboratories International?
plus_minus_icon
What is the 52-Week High and Low Range of Charles River Laboratories International?
plus_minus_icon
What percentage is Charles River Laboratories International down from its 52-Week High?
plus_minus_icon
What percentage is Charles River Laboratories International up from its 52-Week Low?
plus_minus_icon
Current Price
$209.47
$-2.97
(-1.4%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00